Business Context and Reporting Period
This Form 8-K is filed by Galena Biopharma, Inc. (noting a discrepancy with the request metadata which listed "SELLAS Life Sciences Group, Inc.") for the reporting period ending May 13, 2013. The filing addresses a change in the company's independent registered public accounting firm.
Key Financial Metrics
The filing text does not provide specific financial data such as revenue, profit, cash flow, margins, debt, or liquidity. The document focuses exclusively on corporate governance regarding the audit firm.
Material Changes
- Dismissal of Former Accountant: On May 13, 2013, the Audit Committee dismissed BDO USA, LLP as the independent registered public accounting firm.
- Engagement of New Accountant: On May 16, 2013, the Audit Committee engaged Moss Adams LLP as the new independent registered public accounting firm.
- Audit History: BDO's reports for fiscal years ended December 31, 2012, and 2011 contained no adverse opinions, disclaimers, or qualifications. There were no disagreements with BDO regarding accounting principles, practices, or audit scope.
Guidance, Outlook, and Risks
The filing contains no financial guidance, outlook, or management commentary regarding business operations. It confirms that no reportable events or disagreements occurred during the tenure of the former accountant. The company has received a letter from BDO (Exhibit 16.1) stating their agreement with the disclosures made in this report.
Investor Verification Checklist
- Verify the reason for the change in auditors, as the filing states no disagreements occurred.
- Confirm the transition timeline between BDO USA, LLP and Moss Adams LLP.
- Review the attached letter from BDO (Exhibit 16.1) for any additional context not summarized in the main text.
- Note the discrepancy between the company name in the request metadata ("SELLAS Life Sciences Group, Inc.") and the actual registrant in the filing ("Galena Biopharma, Inc.").